Dual GIP/GLP-1 Modulator • Appetite Signaling • Metabolic Research
Tirzepatide is an advanced dual agonist peptide designed to activate both GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. This dual-pathway mechanism makes it one of the most powerful and innovative peptides in metabolic, appetite, and endocrine research.
This capsule format delivers 500 mcg (0.5 mg) of Tirzepatide per tablets, ideal for micro-dosing studies, dose-response models, metabolic tracking, and GLP-1/GIP pathway exploration.
CAPSULE FORMAT DETAILS
Strength Per Capsule:
- 500 mcg (0.5 mg) Tirzepatide
Quantity:
- 25 capsules per bottle
(Parfait pour des kits d’essai, micro-dosing, ou starter packs.)
Format:
- Oral research capsules
- Laboratory-grade excipients for stability and consistency
Form & Stability
All Peptide Labs research capsules are produced with 99%+ purity for reliability and reproducibility.
Purity:
- 99%+ (HPLC-tested)
Storage:
- Store in a cool, dry environment
- Keep away from heat, moisture, and direct light
- Keep bottle tightly sealed
Shelf Life:
- Up to 2 years unopened under proper storage conditions
RESEARCH APPLICATIONS OVERVIEW
- Dual GIP/GLP-1 receptor activation
- Appetite & hunger pathway analysis
- Energy balance & satiety research
- Glucose and insulin modulation
- Metabolic rate & lipid oxidation studies
- Endocrine signaling
- Digestive and nutrient absorption modeling
- Multi-incretin hormone biology
